NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use

Stock Information for NeuroOne Medical Technologies Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NeuroOne Medical Technologies Corporation

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
NeuroOne® Announces First Implant of OneRF(TM) Ablation Electrodes
NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.
NeuroOne® Initiates Limited Commercial Launch of OneRF(TM) Ablation System
NeuroOne® to Participate in the 36th Annual Roth Conference
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.